메뉴 건너뛰기




Volumn 15, Issue 1_suppl, 2009, Pages 05S-08S

Oral Antithrombotic Inhibitors: Dabigatran Etexilate, Meeting an Unmet Need?

Author keywords

anticoagulants; dabigatran; oral antithrombotic inhibitors

Indexed keywords

DABIGATRAN ETEXILATE; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; THROMBIN; ANTICOAGULANT AGENT; BENZIMIDAZOLE DERIVATIVE; FIBRINOLYTIC AGENT; PYRIDINE DERIVATIVE;

EID: 77957090426     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029609344427     Document Type: Article
Times cited : (5)

References (5)
  • 1
    • 46049090201 scopus 로고    scopus 로고
    • Colwell prevention of venous thromboembolism: American college of chest physicians evidence-based clinical practice guidelines
    • William H. Geerts, David Bergqvist, Graham F. Pineo, et al. Colwell prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2008;133(suppl 6):381s-453s.
    • (2008) Chest , vol.133 , pp. 381-453
    • Geerts, W.H.1    Bergqvist, D.2    Pineo, G.F.3
  • 2
    • 84994134811 scopus 로고    scopus 로고
    • Pharmacology, pharmacokinetics and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor
    • PRESS
    • Joachim Stangier, Andreas Clemens. Pharmacology, pharmacokinetics and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor. Clin Appl Thromb/Hemost. IN PRESS.
    • Clin Appl Thromb/Hemost.
    • Stangier, J.1    Clemens, A.2
  • 3
    • 84994194043 scopus 로고    scopus 로고
    • Dabigatran etexilate for the prophylaxis of venous thromboembolism after hip or knee replacement: Rationale for dose regimen
    • PRESS
    • Ola E. Dahl. Dabigatran etexilate for the prophylaxis of venous thromboembolism after hip or knee replacement: rationale for dose regimen. Clin Appl Thromb/Hemost. IN PRESS.
    • Clin Appl Thromb/Hemost.
    • Ola, E.1    Dahl2
  • 4
    • 84994063783 scopus 로고    scopus 로고
    • Dabigatran etexilate: Pivotal trials for venous thromboembolism prophylaxis after hip or knee arthroplasty
    • PRESS
    • Bengt I. Eriksson, Richard J. Friedman. Dabigatran etexilate: pivotal trials for venous thromboembolism prophylaxis after hip or knee arthroplasty. Clin Appl Thromb/Hemost. IN PRESS.
    • Clin Appl Thromb/Hemost.
    • Eriksson, B.I.1    Friedman, R.J.2
  • 5
    • 84994185440 scopus 로고    scopus 로고
    • Dabigatran etexilate: Future directions in anticoagulant treatment
    • PRESS
    • Sam Schulman, Paul A. Reilly. Dabigatran etexilate: future directions in anticoagulant treatment. Clin Appl Thromb/Hemost. IN PRESS.
    • Clin Appl Thromb/Hemost.
    • Schulman, S.1    Reilly, P.A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.